180 related articles for article (PubMed ID: 29679741)
1. Pneumolysin-damaged cells benefit from non-homogeneous toxin binding to cholesterol-rich membrane domains.
Drücker P; Bachler S; Wolfmeier H; Schoenauer R; Köffel R; Babiychuk VS; Dittrich PS; Draeger A; Babiychuk EB
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):795-805. PubMed ID: 29679741
[TBL] [Abstract][Full Text] [Related]
2. Active release of pneumolysin prepores and pores by mammalian cells undergoing a Streptococcus pneumoniae attack.
Wolfmeier H; Radecke J; Schoenauer R; Koeffel R; Babiychuk VS; Drücker P; Hathaway LJ; Mitchell TJ; Zuber B; Draeger A; Babiychuk EB
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2498-2509. PubMed ID: 27481675
[TBL] [Abstract][Full Text] [Related]
3. Ca²⁺-dependent repair of pneumolysin pores: A new paradigm for host cellular defense against bacterial pore-forming toxins.
Wolfmeier H; Schoenauer R; Atanassoff AP; Neill DR; Kadioglu A; Draeger A; Babiychuk EB
Biochim Biophys Acta; 2015 Sep; 1853(9):2045-54. PubMed ID: 25219550
[TBL] [Abstract][Full Text] [Related]
4. Studies on the structure and mechanism of a bacterial protein toxin by analytical ultracentrifugation and small-angle neutron scattering.
Gilbert RJ; Heenan RK; Timmins PA; Gingles NA; Mitchell TJ; Rowe AJ; Rossjohn J; Parker MW; Andrew PW; Byron O
J Mol Biol; 1999 Nov; 293(5):1145-60. PubMed ID: 10547292
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.
Badgujar DC; Anil A; Green AE; Surve MV; Madhavan S; Beckett A; Prior IA; Godsora BK; Patil SB; More PK; Sarkar SG; Mitchell A; Banerjee R; Phale PS; Mitchell TJ; Neill DR; Bhaumik P; Banerjee A
PLoS Pathog; 2020 Nov; 16(11):e1009016. PubMed ID: 33216805
[TBL] [Abstract][Full Text] [Related]
6. Changes in astrocyte shape induced by sublytic concentrations of the cholesterol-dependent cytolysin pneumolysin still require pore-forming capacity.
Förtsch C; Hupp S; Ma J; Mitchell TJ; Maier E; Benz R; Iliev AI
Toxins (Basel); 2011 Jan; 3(1):43-62. PubMed ID: 22069689
[TBL] [Abstract][Full Text] [Related]
7. Incomplete pneumolysin oligomers form membrane pores.
Sonnen AF; Plitzko JM; Gilbert RJ
Open Biol; 2014 Apr; 4(4):140044. PubMed ID: 24759615
[TBL] [Abstract][Full Text] [Related]
8. The Yin and Yang of Pneumolysin During Pneumococcal Infection.
Pereira JM; Xu S; Leong JM; Sousa S
Front Immunol; 2022; 13():878244. PubMed ID: 35529870
[TBL] [Abstract][Full Text] [Related]
9. Bacterial pore-forming toxin pneumolysin: Cell membrane structure and microvesicle shedding capacity determines differential survival of cell types.
Larpin Y; Besançon H; Iacovache MI; Babiychuk VS; Babiychuk EB; Zuber B; Draeger A; Köffel R
FASEB J; 2020 Jan; 34(1):1665-1678. PubMed ID: 31914676
[TBL] [Abstract][Full Text] [Related]
10. β-sitosterol interacts with pneumolysin to prevent Streptococcus pneumoniae infection.
Li H; Zhao X; Wang J; Dong Y; Meng S; Li R; Niu X; Deng X
Sci Rep; 2015 Dec; 5():17668. PubMed ID: 26631364
[TBL] [Abstract][Full Text] [Related]
11. Membrane perforation by the pore-forming toxin pneumolysin.
Vögele M; Bhaskara RM; Mulvihill E; van Pee K; Yildiz Ö; Kühlbrandt W; Müller DJ; Hummer G
Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13352-13357. PubMed ID: 31209022
[TBL] [Abstract][Full Text] [Related]
12. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms.
Shak JR; Ludewick HP; Howery KE; Sakai F; Yi H; Harvey RM; Paton JC; Klugman KP; Vidal JE
mBio; 2013 Sep; 4(5):e00655-13. PubMed ID: 24023386
[TBL] [Abstract][Full Text] [Related]
13. Two structural transitions in membrane pore formation by pneumolysin, the pore-forming toxin of Streptococcus pneumoniae.
Gilbert RJ; Jiménez JL; Chen S; Tickle IJ; Rossjohn J; Parker M; Andrew PW; Saibil HR
Cell; 1999 May; 97(5):647-55. PubMed ID: 10367893
[TBL] [Abstract][Full Text] [Related]
14. Pneumolysin: a double-edged sword during the host-pathogen interaction.
Marriott HM; Mitchell TJ; Dockrell DH
Curr Mol Med; 2008 Sep; 8(6):497-509. PubMed ID: 18781957
[TBL] [Abstract][Full Text] [Related]
15. Degradation products of the extracellular pathogen Streptococcus pneumoniae access the cytosol via its pore-forming toxin.
Lemon JK; Weiser JN
mBio; 2015 Jan; 6(1):. PubMed ID: 25604786
[TBL] [Abstract][Full Text] [Related]
16. [Research progress in pneumolysin].
Rui W; Nie K; Fang R
Wei Sheng Wu Xue Bao; 2017 Mar; 57(3):333-40. PubMed ID: 29756432
[TBL] [Abstract][Full Text] [Related]
17. Host-to-Host Transmission of Streptococcus pneumoniae Is Driven by Its Inflammatory Toxin, Pneumolysin.
Zafar MA; Wang Y; Hamaguchi S; Weiser JN
Cell Host Microbe; 2017 Jan; 21(1):73-83. PubMed ID: 28081446
[TBL] [Abstract][Full Text] [Related]
18. Glucose and Oxygen Levels Modulate the Pore-Forming Effects of Cholesterol-Dependent Cytolysin Pneumolysin from
Hoffet MS; Tomov NS; Hupp S; Mitchell TJ; Iliev AI
Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922127
[TBL] [Abstract][Full Text] [Related]
19. Formation of pre-pore complexes of pneumolysin is accompanied by a decrease in short-range order of lipid molecules throughout vesicle bilayers.
Faraj BHA; Collard L; Cliffe R; Blount LA; Lonnen R; Wallis R; Andrew PW; Hudson AJ
Sci Rep; 2020 Mar; 10(1):4585. PubMed ID: 32165654
[TBL] [Abstract][Full Text] [Related]
20. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae.
Rossjohn J; Gilbert RJ; Crane D; Morgan PJ; Mitchell TJ; Rowe AJ; Andrew PW; Paton JC; Tweten RK; Parker MW
J Mol Biol; 1998 Nov; 284(2):449-61. PubMed ID: 9813129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
